- Home
- Publications
- Publication Search
- Publication Details
Title
Exploiting Human NK Cells in Tumor Therapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-17
DOI
10.3389/fimmu.2019.03013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on Board
- (2019) Maria Cristina Mingari et al. TRENDS IN IMMUNOLOGY
- Natural killer cells: From surface receptors to the cure of high‐risk leukemia (Ceppellini Lecture)
- (2019) Michela Falco et al. HLA
- Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD‐1 receptor
- (2019) Nicola Tumino et al. INTERNATIONAL JOURNAL OF CANCER
- PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays
- (2019) Enrico Munari et al. HUMAN PATHOLOGY
- A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors
- (2019) Salah-Eddine Bentebibel et al. Cancer Discovery
- Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing
- (2019) Tiziano Ingegnere et al. Frontiers in Immunology
- Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions
- (2019) Francesca Romana Mariotti et al. Frontiers in Immunology
- An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More
- (2019) Massimo Vitale et al. Frontiers in Immunology
- Adoptive cell therapy using engineered natural killer cells
- (2019) Katayoun Rezvani BONE MARROW TRANSPLANTATION
- PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation
- (2019) Nicola Tumino et al. LEUKEMIA
- NK Cell-Based Immunotherapy for Hematological Malignancies
- (2019) Simona Sivori et al. Journal of Clinical Medicine
- PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non–Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs
- (2018) Enrico Munari et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
- (2018) Rizwan Romee et al. BLOOD
- Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
- (2018) May Daher et al. CURRENT OPINION IN IMMUNOLOGY
- PD-L1 Expression Heterogeneity in Non–Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole Sections
- (2018) Enrico Munari et al. Journal of Thoracic Oncology
- ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
- (2018) John M Wrangle et al. LANCET ONCOLOGY
- Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
- (2018) Vito Pistoia et al. Frontiers in Immunology
- Late Development of FcεRγneg Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients
- (2018) Letizia Muccio et al. Frontiers in Immunology
- Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma
- (2018) Concetta Quintarelli et al. OncoImmunology
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression
- (2018) Francesca R. Mariotti et al. OncoImmunology
- A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study
- (2017) Premal H. Thaker et al. GYNECOLOGIC ONCOLOGY
- Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
- (2017) Silvia Pesce et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
- (2017) Zachary B. Davis et al. SEMINARS IN IMMUNOLOGY
- IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid
- (2017) D. Croxatto et al. OncoImmunology
- Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen–Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency
- (2016) Giuseppina Li Pira et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
- (2016) D. A. Vallera et al. CLINICAL CANCER RESEARCH
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF
- (2016) Francesca Moretta et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cellular players of hematopoietic stem cell mobilization in the bone marrow niche
- (2016) Joshua Tay et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- A novel method for mapping village-scale outdoor resting microhabitats of the primary African malaria vector, Anopheles gambiae
- (2016) Julius R. Dewald et al. MALARIA JOURNAL
- IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation
- (2016) G. C. Sim et al. Cancer Immunology Research
- T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR- +/CD19+ lymphocytes
- (2015) I. Airoldi et al. BLOOD
- Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias
- (2015) Gabriella Pietra et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma
- (2015) F. Sabbatino et al. CLINICAL CANCER RESEARCH
- CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT
- (2015) F Cichocki et al. LEUKEMIA
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
- (2014) Loren Gragert et al. NEW ENGLAND JOURNAL OF MEDICINE
- NK cells from pleural effusions are potent antitumor effector cells
- (2013) Magali Terme et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: A novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation
- (2013) Franco Locatelli et al. IMMUNOLOGY LETTERS
- Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
- (2013) T. Carmenate et al. JOURNAL OF IMMUNOLOGY
- NK cells from malignant pleural effusions are potent antitumor effectors
- (2013) Paola Vacca et al. OncoImmunology
- G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells
- (2012) Ariane Luyckx et al. CLINICAL IMMUNOLOGY
- NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation
- (2012) Paola Vacca et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
- (2012) Jing Ni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1
- (2012) Jeffrey M. Venstrom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?
- (2011) M. Della Chiesa et al. BLOOD
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
- (2008) D. Pende et al. BLOOD
- Natural killer cell–directed therapies: moving from unexpected results to successful strategies
- (2008) Magali Terme et al. NATURE IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started